TABLE 4.
Author [ref.] | Year | Participants | AHI cutoff events·h−1 |
Sample size |
Age years M/F |
Baseline BMI kg·m−2 |
Baseline ESS |
Design | CPAP duration |
CPAP compliance h per night M/F |
Outcomes | Main findings: effect of CPAP |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Questiornnaire-based assessment | ||||||||||||
Batool-Anwar [47] | 2014 | Active CPAP | ≥10 | 117 | 54.0±13.0/ 55.0±13.0 | 33.0±6.3*/36.0 ±11.0 | 10.0±4. 0/ 10.7±4.6 | Sham-controlled, parallel; RCT | 4 months | 4.0±2.9** /3.5±2.8 | Physical activity questionnaire | ↔ total energy expenditure; ↑ recreational calories expended in females in CPAP group at 4 months |
Sham CPAP | ≥10 | 114 | 55.0±14.0/ 54.0±13.0 | 31.0±5.5*/ 34.0±8.8 | 9.7±4.3/ 9.7±3.7 | 4 months | 2.6±2.6**/2.9±2.6 | |||||
Billings [69] | 2013 | OSA-CPAP compliant | ≥15 | 21 | 50.5±2.0 | 36.0±2.0 | 15.4±0.7 | Baseline to post-treatment | 2 weeks; 3 months; 6 months | 2 weeks 5.2±0.3 3 months 5.1±0.3 6 months 5.7±0.3 |
Physical activity questionnaire | ↑ daily hours of activity; ↑ strenuous weekly activity |
Salord [70] | 2015 | CPAP | >30 | 42 | 48.5±8.6 | 45.7±5.0 | 7.9±4.5 | Placebo-controlled, parallel; RCT | 3 months | 5.4±1.6 | Physical activity questionnaire | ↔ METS min per week between groups |
CT | >30 | 38 | 44.6±9.4 | 49.3±6.6* | 7.9±5.2 | 3 months | ||||||
Accelerometry-based assessment | ||||||||||||
Chasens [71] | 2014 | Active CPAP | ≥10 | 23 | 55.6±10.6 | 35.5±6.2 | 11.4±4.6 | Placebo-controlled, parallel; RCT | 4 weeks | 96–489 min per night | SenseWear armband | ↑ steps walked in active versus sham CPAP |
Sham CPAP | ≥10 | 12 | 10.6±3.7 | 8 weeks | ||||||||
Diamanti [34] | 2013 | OSA-CPAP compliant | ≥15 | 24 | 51.9±10.6 | 34.4±6.5 | 8.3±4.0 | Baseline to post-treatment | 6–11 months | 6.3±0.8 | Ankle accelerometer | ↔ energy expenditure or steps per day after treatment |
Igelstrom [38] | 2014 | OSA | ≥15 | 35 | 53.0±11.0 | 33.6±4.3 | N/R | Baseline to post-treatment; RCT | 6 months | >4 in 73% of participants | SenseWear armband | ↓ sedentary time after treatment ↔ MVPA or steps per day |
Jean [72] | 2015 | OSA | >5 | 62 | 53.0±13.0 | 38.0±11.0 | N/R | Baseline to post-treatment | 3 months 7 months |
>4 in 73% of participants | Pedometer | ↑ steps per day at 3 and 7 month follow-up |
Kerley [73] | 2012 | OSA | N/R | 15 | 54.7 | N/R | N/R | Baseline to post-treatment | 3 months | N/R | SenseWear armband | Trend toward ↑ total daily energy expenditure and physical activity |
Lemmer [74] | 2016 | OSA | >30 | 7 | 60.5±8.1# | 35.0±4.7# | N/R | Baseline to post-treatment | 2 months | N/R | Wrist accelerometer | ↓ sleep movement arousals after treatment |
Mansukhani [75] | 2012 | OSA | x̄ = 16 | 3 | 44.0±7.0 | N/R | N/R | Baseline to post-treatment | 1 month | N/R | Accelerometer | Trend toward ↑ nonexercise activity thermogenesis (p=0.08) and upright motion (p=0.07) after treatment |
Mendelson [76] | 2014 | CPAP, SC | >15 | 42 | 63.0±9.0¶ | 30.2±5.7¶ | 8.7±4.5¶ | Placebo-controlled, parallel; RCT | 4 months | 4.16±2.8 | SenseWear armband | ↔ steps per day; energy expenditure (kcal) or METS after treatment in either group |
CPAP, TM | >15 | 40 | 62.0±9.0¶ | 29.6±3.0¶ | 7.2±4.3¶ | 3.12±3.0 | ||||||
Pamidi [49] | 2015 | CPAP | ≥5 | 26 | 53.8±6.2 | 36.8±7.8 | 10.0±5.9 | Placebo-controlled, parallel; RCT | 2 weeks | 8 | Wrist accelerometer | ↔ physical activity levels between groups |
Oral placebo | ≥5 | 13 | 55.2±8.4 | 32.7±4.3 | 10.9±5.0 | 2 weeks | ||||||
Tachikawa [48] | 2016 | OSA | >20 | 63 | 60.6±10.0 | 27.9±3.8 | 8.7±5.3 | Baseline to post-treatment | 1 day; 3 months | 4.5±1.6 | Wrist accelerometer | ↔ physical activity levels |
West [77] | 2007 | Active CPAP | N/R+ | 19 | 57.8±10.4 | 36.6±4.9 | 14.7±3.5 | Placebo-controlled, parallel; RCT | 3 months | 3.6±2.8 | Wrist accelerometer | ↔ physical activity levels during most active least active periods |
Sham CPAP | N/R+ | 21 | 54.5±9.4 | 36.8±4.6 | 13.6±3.5 | 3.3±3.0 | ||||||
West [78] | 2009 | Active CPAP | N/R+ | 16 | 57.2±11.2 | 37.4±4.4 | 13.4±2.6 | Placebo-controlled, parallel; RCT | 3 months | 3.8±2.8 | Wrist accelerometer | ↔ mean hourly physical activity over 24 h |
Sham CPAP | N/R+ | 20 | 54.1±9.8 | 36.2± 4.3 | 13.3±3.4 | 3.7±2.9 |
Data are presented as n or mean±SD, unless otherwise stated. AHI: apnoea–hypopnoea index; M: male; F: female; BMI: body mass index; ESS: Epworth sleepiness scale; RCT: randomised controlled trial; METS: metabolic equivalents; CT: conservative treatment; N/R: not reported; MVPA: moderate-to-vigorous physical activity; SC: standard care; TM: telemedicine. ↑: significant increase; ↓: significant decrease.
full OSA group at baseline, not just those with physical activity measures;
full groups at baseline, including dropouts;
>10 dips·h−1 in oxygen saturation of >4%.
p<0.05 M versus F;
p<0.05 active versus sham within males.